Hassan R - Search Results

1

Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell.

Kalra N, Zhang J, Yu Y, Ho M, Merino M, Cao L, Hassan R. Kalra N, et al. Among authors: hassan r. Int J Cancer. 2012 Nov 1;131(9):2143-52. doi: 10.1002/ijc.27471. Epub 2012 Apr 24. Int J Cancer. 2012. PMID: 22323052 Free PMC article.

2

111Indium-labeled monoclonal antibody K1: biodistribution study in nude mice bearing a human carcinoma xenograft expressing mesothelin.

Hassan R, Wu C, Brechbiel MW, Margulies I, Kreitman RJ, Pastan I. Hassan R, et al. Int J Cancer. 1999 Feb 9;80(4):559-63. doi: 10.1002/(sici)1097-0215(19990209)80:4<559::aid-ijc13>3.0.co;2-y. Int J Cancer. 1999. PMID: 9935157

3

Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.

Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I. Ho M, et al. Among authors: hassan r. Clin Cancer Res. 2005 May 15;11(10):3814-20. doi: 10.1158/1078-0432.CCR-04-2304. Clin Cancer Res. 2005. PMID: 15897581

4

New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.

Onda M, Willingham M, Nagata S, Bera TK, Beers R, Ho M, Hassan R, Kreitman RJ, Pastan I. Onda M, et al. Among authors: hassan r. Clin Cancer Res. 2005 Aug 15;11(16):5840-6. doi: 10.1158/1078-0432.CCR-05-0578. Clin Cancer Res. 2005. PMID: 16115924

5

Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.

Yokokawa J, Palena C, Arlen P, Hassan R, Ho M, Pastan I, Schlom J, Tsang KY. Yokokawa J, et al. Among authors: hassan r. Clin Cancer Res. 2005 Sep 1;11(17):6342-51. doi: 10.1158/1078-0432.CCR-05-0596. Clin Cancer Res. 2005. PMID: 16144939 Free PMC article.

6

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.

Hassan R, Remaley AT, Sampson ML, Zhang J, Cox DD, Pingpank J, Alexander R, Willingham M, Pastan I, Onda M. Hassan R, et al. Clin Cancer Res. 2006 Jan 15;12(2):447-53. doi: 10.1158/1078-0432.CCR-05-1477. Clin Cancer Res. 2006. PMID: 16428485

7

Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma.

Onda M, Nagata S, Ho M, Bera TK, Hassan R, Alexander RH, Pastan I. Onda M, et al. Among authors: hassan r. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4225-31. doi: 10.1158/1078-0432.CCR-06-0472. Clin Cancer Res. 2006. PMID: 16857795

8

Synergistic antitumor activity of taxol and immunotoxin SS1P in tumor-bearing mice.

Zhang Y, Xiang L, Hassan R, Paik CH, Carrasquillo JA, Jang BS, Le N, Ho M, Pastan I. Zhang Y, et al. Among authors: hassan r. Clin Cancer Res. 2006 Aug 1;12(15):4695-701. doi: 10.1158/1078-0432.CCR-06-0346. Clin Cancer Res. 2006. PMID: 16899620

9

Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts.

Hassan R, Williams-Gould J, Steinberg SM, Liewehr DJ, Yokokawa J, Tsang KY, Surawski RJ, Scott T, Camphausen K. Hassan R, et al. Clin Cancer Res. 2006 Aug 15;12(16):4983-8. doi: 10.1158/1078-0432.CCR-06-0441. Clin Cancer Res. 2006. PMID: 16914588

10

Mesothelin is shed from tumor cells.

Ho M, Onda M, Wang QC, Hassan R, Pastan I, Lively MO. Ho M, et al. Among authors: hassan r. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1751. doi: 10.1158/1055-9965.EPI-06-0479. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16985043 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,191 results

Search Page

Filters